explore -WSS

explore

author：focus 2025-09-30 16:59:46 - browse：75

The sign of University of Texas MD Anderson Cancer Center in Houston, Texas in front of the Sheikh Zayed Building — coverage from STAT — Adobe

Early last year, MD Anderson Cancer Center leadership had a problem on their hands: a contentious dispute between one of its most powerful researchers and a junior scientist over authorship, credit, and charges of verbal abuse. High-ranking officials at the cancer center tried — and failed — to resolve the feud, and documents obtained by STAT shed new light on the deep divisions at the heart of this case.

The Texas cancer center outsourced assessing the conflict between early-career nephrologist Jamie Lin and leading oncologist Padmanee Sharma to the law firm Ropes & Gray. The firm investigated the authorship and scientific credit portions of the dispute and concluded that Sharma was likely responsible for a scientific hypothesis at the heart of the feud and should be named as a co-senior author on a key manuscript.

But a separate investigation, commissioned by Lin and conducted by a former official at the federal Office of Research Integrity, tells a somewhat different story. That review looked into plagiarism after Sharma claimed Lin had wrongly omitted the senior researcher as an author from a manuscript built on research to which Sharma contributed. But this second investigation found no evidence of plagiarism between two manuscripts submitted to the journals Cancer Immunology Research and Journal of Clinical Investigation Insight.

Lin provided STAT with copies of an executive summary of the Ropes & Gray investigation as well as the conclusions of the plagiarism investigation. These documents are alluded to in legal filings but have not been previously reported. Lin has filed a lawsuit against Sharma in the Harris County District Court alleging retaliation, harassment, threatening, and intellectual theft by Sharma; she’s also asking for $5 million in damages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Readout Newsletter: Geron, Novo Nordisk, WuXi updates

entertainment

WSS

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Health AI adoption puts security, privacy startups on investors' radar

What don’t we know about an Alzheimer’s drug side effect?

UnitedHealth’s Optum accused of antitrust violations in California

UnitedHealth increases loan offers after Change Healthcare outage

SCOTUS questions limit to govt efforts to fight misinformation

hotspot

explore

focus

ChatGPT in medicine: STAT answers readers' burning questions

Intermittent fasting comes with a heart risk? Not so fast

Moonlake's readout produced a cash windfall. Risks remain

Colonoscopy prep: Liquid

Drug repurposing or repositioning? The language matters

U.K. researchers warn about biases in medical devices, algorithms

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Orchard's therapy for neuron disease in children wins FDA approval

At least 13 dead in Texas as scorching temps continue

Despite FDA concern, risk that CAR

entertainment

U.K. researchers warn about biases in medical devices, algorithms

Takeda, Janssen join wearable maker to measure scratching

Flagship Pioneering launches a new biotech in two countries

With clinical trial data readouts, here's how to spot spin

Creating egg and sperm cells from stem cells raises ethical issues

Neuroscience’s long legacy of racism

explore

hotspot

entertainment

explore